Carbonic Anhydrase Inhibitors: Synthesis and Inhibition Against Isozymes I, II and IV of Topically Acting Antiglaucoma Sulfonamides Incorporatingcis-5-Norbornene-endo-3-Carboxy-2-Carboxamido Moieties
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Enzyme Inhibition
- Vol. 16 (2), 113-123
- https://doi.org/10.1080/14756360109162361
Abstract
Sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties in their molecules were prepared by reaction of cis-5-norbornene-endo-2,3-dicarboxylic anhydride with aromatic/heterocyclic sulfonamides possessing free amino, hydrazino, or imino groups. Some of these compounds showed very good CA II and CA IV inhibitory properties, with affinities for the enzymes in the low nanomolar range. Some of the most active CA II inhibitors reported here have been formulated as aqueous solutions for topical administration as antiglaucoma agents in normotensive rabbits. Some of the derivatives incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido and aromatic sulfonamide moieties (as sodium salts) showed effective and longer lasting intraocular pressure (IOP) lowering as compared to dorzolamide, a widely used topical antiglaucoma drug. Compounds incorporating cis-5-norbornene-endo-2,3-carboximido moieties, although stronger in vitro CA inhibitors as compared to the corresponding cis-5-norbomene-endo-3-carboxy-2-carbox-amido-derivatives, showed no topical IOP lowering properties, probably due to their very poor water solubility.Keywords
This publication has 33 references indexed in Scilit:
- Carbonic anhydrase inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000
- Pharmacological Therapy for GlaucomaDrugs, 2000
- Antiglaucoma medications: A review of safety and tolerability issues related to their useClinical Therapeutics, 2000
- Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt®)Survey of Ophthalmology, 2000
- Activation of carbonic anhydrase isozymesPublished by Springer Science and Business Media LLC ,2000
- Evolution and distribution of the carbonic anhydrase gene familiesPublished by Springer Science and Business Media LLC ,2000
- Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitorsProgress in Retinal and Eye Research, 1999
- Contact allergy to dorzolamide eyedropsContact Dermatitis, 1998
- The Kinetics of HCO3− Synthesis Related to Fluid Secretion, pH Control, and CO2 EliminationAnnual Review of Physiology, 1988
- Carbonic anhydrase: chemistry, physiology, and inhibitionPhysiological Reviews, 1967